Establishment Labs Holdings Inc (ESTA)
42.72
+0.91
(+2.18%)
USD |
NASDAQ |
Nov 21, 16:00
42.72
0.00 (0.00%)
After-Hours: 20:00
Establishment Labs Holdings Profit Margin (Quarterly): -41.47% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | -41.47% |
June 30, 2024 | -38.94% |
March 31, 2024 | -43.59% |
December 31, 2023 | -65.09% |
September 30, 2023 | -76.02% |
June 30, 2023 | -34.48% |
March 31, 2023 | -25.67% |
December 31, 2022 | -30.95% |
September 30, 2022 | -48.65% |
June 30, 2022 | -90.08% |
March 31, 2022 | -15.43% |
December 31, 2021 | -40.19% |
September 30, 2021 | -50.55% |
June 30, 2021 | -16.63% |
March 31, 2021 | -22.90% |
December 31, 2020 | -20.96% |
Date | Value |
---|---|
September 30, 2020 | -18.65% |
June 30, 2020 | -99.98% |
March 31, 2020 | -72.52% |
December 31, 2019 | -22.91% |
September 30, 2019 | -55.90% |
June 30, 2019 | -41.69% |
March 31, 2019 | -51.88% |
December 31, 2018 | -64.12% |
September 30, 2018 | 8.02% |
June 30, 2018 | -39.10% |
March 31, 2018 | -44.07% |
December 31, 2017 | -60.39% |
September 30, 2017 | -145.7% |
June 30, 2017 | -140.2% |
March 31, 2017 | -72.25% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-99.98%
Minimum
Jun 2020
-15.43%
Maximum
Mar 2022
-43.78%
Average
-39.57%
Median
Profit Margin (Quarterly) Benchmarks
Bristol-Myers Squibb Co | 10.18% |
Cassava Sciences Inc | -- |
Aytu BioPharma Inc | 8.89% |
enVVeno Medical Corp | -- |
Onconetix Inc | -2.03K% |
Profit Margin (Quarterly) Related Metrics
Return on Equity | -192.4% |
Return on Assets | -25.06% |
Return on Invested Capital | -31.03% |
Gross Profit Margin (Quarterly) | 63.93% |
Operating Margin (Quarterly) | -32.66% |
Return on Net Operating Assets | -26.42% |